3289-05-2

Upstream product

• 401-78-5 3-bromo-1-trifluoromethylbenzene 
• 41824-88-8 1,2-dibromoethyl methyl ether 

Downstream Products

• 212752-60-8 3-{2-[N-(-S-α-methylbenzyl)amino]-1-methoxyethyl}trifluoromethylbenzene 
• 212752-62-0 3-{2-[N-(+R-α-methylbenzyl)amino]-1-methoxyethyl}trifluoromethylbenzene 
• 3549-17-5 Benzyl-[2-methoxy-2-(3-trifluoromethyl-phenyl)-ethyl]-amine 
• 67287-99-4 6-chloro-7,8-dihydroxy-3-methyl-1-[3-(trifluoromethyl)phenyl]-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide 
• 67287-66-5 6-chloro-7,8-dihydroxy-1-(m-trifluoromethylphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide 
• 80751-89-9 [2-(2-Chloro-3,4-dimethoxy-phenyl)-ethyl]-[2-methoxy-2-(3-trifluoromethyl-phenyl)-ethyl]-methyl-amine 
• 159978-02-6 4-[2-(2-9H-Fluoren-9-yl-acetylamino)-ethyl]-benzoic acid 2-[2-methoxy-2-(3-trifluoromethyl-phenyl)-ethylamino]-ethyl ester 
• 1027718-49-5 4-[2-(2-9H-Fluoren-9-yl-acetylamino)-ethyl]-benzoic acid 2-{benzyl-[2-methoxy-2-(3-trifluoromethyl-phenyl)-ethyl]-amino}-ethyl ester 
• 1027248-86-7 {Benzyl-[2-methoxy-2-(3-trifluoromethyl-phenyl)-ethyl]-amino}-acetic acid ethyl ester 

Relevant academic research and scientific papers

General pharmacology of S 15261, a new concept for treatment of diabetes

The new compound S 15261 (CAS 159978-02-6) is the 1-isomer of 3-[2-[2- [4-[2-(α-Fluorenylacetylamino)ethyl]benzoyloxy]ethylamino]-1- methoxyethyl]trifluoromethylbenzene. The general synthetic pathway used for the preparation of S 15261 and related esters

Ethanolamine benzoate compounds

New ethanolamine benzoate compounds which can be used as medicaments and correspond to the formula: STR1 wherein R is as defined in the description, in the form of racemic compounds and enantiomers. These new compounds and their physiologically tolerable salts can be used therapeutically for treatment of insulin-resistance states.